Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Cardiff Oncology initiated with a Buy at H.C. Wainwright » 06:09
10/22/20
10/22
06:09
10/22/20
06:09
CRDF

Cardiff Oncology

$12.04 /

-1.22 (-9.20%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRDF Cardiff Oncology
$12.04 /

-1.22 (-9.20%)

CRDF Cardiff Oncology
$12.04 /

-1.22 (-9.20%)

10/21/20 Maxim
Cardiff Oncology price target raised to $20 from $14 at Maxim
10/08/20
Fly Intel: Top five analyst initiations
10/08/20 Piper Sandler
Cardiff Oncology initiated with an Overweight at Piper Sandler
09/18/20 Maxim
Cardiff Oncology price target raised to $14 from $6 at Maxim
  • 30
    Sep
CRDF Cardiff Oncology
$12.04 /

-1.22 (-9.20%)

CRDF Cardiff Oncology
$12.04 /

-1.22 (-9.20%)

Yesterday
Periodicals
Katzenberg's streaming service Quibi may shut down, WSJ says » 15:46
10/21/20
10/21
15:46
10/21/20
15:46
DIS

Disney

$127.12 /

+2.05 (+1.64%)

, CMCSA

Comcast

$44.78 /

+0.51 (+1.15%)

, T

AT&T

$26.81 /

+0.04 (+0.15%)

, NFLX

Netflix

$491.34 /

-34.17 (-6.50%)

, AMZN

Amazon.com

$3,207.99 /

-9.82 (-0.31%)

, ROKU

Roku

$223.18 /

+4.78 (+2.19%)

, GOOG

Alphabet

$1,607.80 /

+52.89 (+3.40%)

Jeffrey Katzenberg's…

Jeffrey Katzenberg's mobile streaming service Quibi may be shutting down, wrote the Wall Street Journal's Benjamin Mullin. The service has been plagued by issues almost since inception, including the fact that the coronavirus pandemic sent people home and to streaming services that were suited for larger screen viewing, noted the WSJ story. Katzenberg and CEO Meg Whitman "raised about $1.75B" from the likes of Walt Disney (DIS) NBCUniversal (CMCSA) and AT&T's (T) WarnerMedia for the mobile streaming service, added the story. Other companies in the streaming media space include Netflix (NFLX), Amazon (AMZN), Roku (ROKU), Google (GOOG). Reference Link

ShowHide Related Items >><<
T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

10/20/20 Morgan Stanley
Charter price target raised to $750 from $700 at Morgan Stanley
10/16/20 Citi
Comcast price target raised to $52 from $49 at Citi
10/16/20 Barclays
Comcast price target raised to $48 from $46 at Barclays
10/16/20 Morgan Stanley
Comcast price target raised to $57 from $49 at Morgan Stanley
T AT&T
$26.81 /

+0.04 (+0.15%)

10/19/20 Wolfe Research
AT&T initiated with a Peer Perform at Wolfe Research
10/14/20 Jefferies
Apple price target raised to $140 from $135 at Jefferies
10/05/20
Fly Intel: Top five analyst downgrades
10/05/20 KeyBanc
AT&T downgraded to Underweight from Sector Weight at KeyBanc
NFLX Netflix
$491.34 /

-34.17 (-6.50%)

10/21/20 JPMorgan
Netflix weakness on earnings a buying opportunity, says JPMorgan
10/21/20 KeyBanc
KeyBanc sees Netflix stock weakness as 'an overreaction'
10/21/20 Wells Fargo
Netflix price target raised to $510 from $470 at Wells Fargo
10/21/20 Canaccord
Netflix profits outperformed while subscriber growth slowed, says Canaccord
AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

10/20/20 Citi
Citi likes Amazon head of Q3 results despite Prime Day language
10/19/20 Piper Sandler
Amazon Prime Day sales up 49% year-over-year, says Piper Sandler
10/16/20 Citi
Citi questions if Amazon's Prime Day may disappoint compared to last year
10/15/20 Truist
Truist says indications show Amazon Prime Day again a 'record sales period'
ROKU Roku
$223.18 /

+4.78 (+2.19%)

10/15/20
Fly Intel: Top five analyst downgrades
10/15/20 KeyBanc
KeyBanc downgrades Roku with positive fundamentals priced in
10/15/20 KeyBanc
Roku downgraded to Sector Weight from Overweight at KeyBanc
10/08/20 Citi
Citi calls Roku Channel on Fire TV news 'an extraordinary development'
GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
10/20/20 Jefferies
Alphabet price target raised to $1,850 from $1,800 at Jefferies
10/19/20 Morgan Stanley
ADT Inc. price target lowered to $10 from $17 at Morgan Stanley
T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

  • 17
    Mar
T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

Recommendations
Cardiff Oncology price target raised to $20 from $14 at Maxim » 07:59
10/21/20
10/21
07:59
10/21/20
07:59
CRDF

Cardiff Oncology

$13.37 /

-0.16 (-1.18%)

Maxim analyst Jason…

Maxim analyst Jason McCarthy raised the firm's price target on Cardiff Oncology to $20 from $14 and keeps a Buy rating on the shares. The analyst is citing the company's "positive" ongoing phase 2 trial data of onvansertib in metastatic castration-resistant prostate cancer - mCRPC - presented at the 2020 Prostate Cancer Foundation Retreat, adding that his model now starts to account for proof of concept of the program in that indication. McCarthy adds that Cardiff is also well- capitalized, having completed an $88M equity financing last month.

ShowHide Related Items >><<
CRDF Cardiff Oncology
$13.37 /

-0.16 (-1.18%)

CRDF Cardiff Oncology
$13.37 /

-0.16 (-1.18%)

10/08/20
Fly Intel: Top five analyst initiations
10/08/20 Piper Sandler
Cardiff Oncology initiated with an Overweight at Piper Sandler
09/18/20 Maxim
Cardiff Oncology price target raised to $14 from $6 at Maxim
  • 30
    Sep
CRDF Cardiff Oncology
$13.37 /

-0.16 (-1.18%)

CRDF Cardiff Oncology
$13.37 /

-0.16 (-1.18%)

Earnings
Lithia Motors reports Q3 adj. EPS $6.89, consensus $5.86 » 07:03
10/21/20
10/21
07:03
10/21/20
07:03
LAD

Lithia Motors

$259.25 /

-7.03 (-2.64%)

Reports Q3 revenue…

Reports Q3 revenue $3.62B, consensus $3.57B. Same store used vehicle retail sales increased 11.2% in Q3. Same store F&I per unit increased 9.8% to $1,617 in Q3. Same store total vehicle gross profit per unit increased 28.0% to $4,690 in Q3. "Our strong used vehicle performance and sequential improvements in service, body and parts throughout the quarter, coupled with our strategic cost saving measures taken earlier in the year, led us to the highest quarterly earnings per share in our company's history, more than doubling our adjusted earnings per share compared to the third quarter of last year," said Bryan DeBoer, president and CEO. "This record performance and profitability demonstrate the high performance being achieved at our existing stores and only the very beginning of the benefits to be realized through the activation of Driveway, our ecommerce digital home solution."

ShowHide Related Items >><<
LAD Lithia Motors
$259.25 /

-7.03 (-2.64%)

LAD Lithia Motors
$259.25 /

-7.03 (-2.64%)

10/19/20
Fly Intel: Top five analyst initiations
10/19/20 Seaport Global
Lithia Motors initiated with a Buy at Seaport Global
10/02/20 JPMorgan
Lithia Motors price target raised to $330 from $280 at JPMorgan
10/01/20 Craig-Hallum
Lithia Motors price target raised to $300 from $260 at Craig-Hallum
LAD Lithia Motors
$259.25 /

-7.03 (-2.64%)

  • 01
    Oct
LAD Lithia Motors
$259.25 /

-7.03 (-2.64%)

Hot Stocks
Disney executive blasts California's protocols for reopening theme parks » 06:08
10/21/20
10/21
06:08
10/21/20
06:08
DIS

Disney

$125.03 /

+0.77 (+0.62%)

Disney has blasted…

Disney has blasted California's new protocols for reopening theme parks, saying the strict guidance would significantly complicate the company's efforts to reopen Disneyland. In a statement, Ken Potrock, president of Disneyland Resort, said: "We have proven that we can responsibly reopen" but new California Covid-19 coronavirus "arbitrary" guidelines "will keep us shuttered for the foreseeable future." "Nevertheless, the State of California continues to ignore this fact, instead mandating arbitrary guidelines that it knows are unworkable and that hold us to a standard vastly different from other reopened businesses and state-operated facilities." Potrock called the decision "devastating" for the Anaheim/Southern California community. Reference Link

ShowHide Related Items >><<
DIS Disney
$125.03 /

+0.77 (+0.62%)

DIS Disney
$125.03 /

+0.77 (+0.62%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
DIS Disney
$125.03 /

+0.77 (+0.62%)

DIS Disney
$125.03 /

+0.77 (+0.62%)

DIS Disney
$125.03 /

+0.77 (+0.62%)

DIS Disney
$125.03 /

+0.77 (+0.62%)

Periodicals
California offers guidance for reopening theme parks, NY Times reports » 06:03
10/21/20
10/21
06:03
10/21/20
06:03
DIS

Disney

$125.03 /

+0.77 (+0.62%)

, CMCSA

Comcast

$44.27 /

-0.04 (-0.09%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

California health…

California health officials have issued guidance for reopening theme parks in the state, saying large parks must be in the state's "yellow" tier for economic recovery, with the virus largely contained, The New York Times' Tariro Mzezewa reports. Orange County, home to Disneyland (DIS), is currently in the "red," or second, tier and Los Angeles County, Universal Studios' (CMCSA) location, is currently in the "purple" tier. The "yellow" tier requires there be fewer than one case a day per 100,000 residents and a testing positivity rate of less than 2%. The parks have been closed since March. Reference Link

ShowHide Related Items >><<
DIS Disney
$125.03 /

+0.77 (+0.62%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CMCSA Comcast
$44.27 /

-0.04 (-0.09%)

DIS Disney
$125.03 /

+0.77 (+0.62%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
CMCSA Comcast
$44.27 /

-0.04 (-0.09%)

10/20/20 Morgan Stanley
Charter price target raised to $750 from $700 at Morgan Stanley
10/16/20 Citi
Comcast price target raised to $52 from $49 at Citi
10/16/20 Barclays
Comcast price target raised to $48 from $46 at Barclays
10/16/20 Morgan Stanley
Comcast price target raised to $57 from $49 at Morgan Stanley
CMCSK Comcast
$0.00 /

+ (+0.00%)

10/07/20 Benchmark
Benchmark would be 'aggressive buyer' of Comcast amid broader market weakness
09/22/20 Benchmark
Comcast price target raised to $60 from $54 at Benchmark
09/16/20 Pivotal Research
Comcast price target raised to $60 from $52 at Pivotal Research
07/01/20
Fly Intel: Top five analyst upgrades
DIS Disney
$125.03 /

+0.77 (+0.62%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CMCSA Comcast
$44.27 /

-0.04 (-0.09%)

DIS Disney
$125.03 /

+0.77 (+0.62%)

CMCSA Comcast
$44.27 /

-0.04 (-0.09%)

DIS Disney
$125.03 /

+0.77 (+0.62%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CMCSA Comcast
$44.27 /

-0.04 (-0.09%)

DIS Disney
$125.03 /

+0.77 (+0.62%)

CMCSA Comcast
$44.27 /

-0.04 (-0.09%)

Tuesday
Hot Stocks
Netflix says 'thrilled to be competing with Disney' » 16:08
10/20/20
10/20
16:08
10/20/20
16:08
NFLX

Netflix

$526.10 /

-4.56 (-0.86%)

, DIS

Disney

$125.06 /

+0.8 (+0.64%)

, CMCSA

Comcast

$44.30 /

-0.01 (-0.02%)

, T

AT&T

$26.80 /

-0.09 (-0.33%)

Netflix (NFLX) said in…

Netflix (NFLX) said in its quarterly letter to investors: "This past quarter, we saw the debut of Comcast's Peacock, which comes on the heels of the launch of HBO Max and Disney+. Disney's recent management reorganization signals that it is embracing the shift to streaming entertainment. We're thrilled to be competing with Disney and a growing number of other players to entertain people; both consumers and content creators will benefit from our mutual desire to bring the best stories to audiences all over the world. We'll continue to focus on pleasing our members and improving our service as quickly as possible so that we can be everyone's first choice for online entertainment."

ShowHide Related Items >><<
T AT&T
$26.80 /

-0.09 (-0.33%)

NFLX Netflix
$526.10 /

-4.56 (-0.86%)

DIS Disney
$125.06 /

+0.8 (+0.64%)

CMCSA Comcast
$44.30 /

-0.01 (-0.02%)

NFLX Netflix
$526.10 /

-4.56 (-0.86%)

10/16/20 BofA
Netflix price target raised to $670 from $575 at BofA
10/16/20 Morgan Stanley
Netflix price target raised to $630 from $600 at Morgan Stanley
10/15/20 Canaccord
Netflix price target raised to $630 from $550 at Canaccord
10/15/20 Jefferies
Netflix setup into Q3 earnings 'a bit challenging,' says Jefferies
DIS Disney
$125.06 /

+0.8 (+0.64%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
CMCSA Comcast
$44.30 /

-0.01 (-0.02%)

10/20/20 Morgan Stanley
Charter price target raised to $750 from $700 at Morgan Stanley
10/16/20 Citi
Comcast price target raised to $52 from $49 at Citi
10/16/20 Barclays
Comcast price target raised to $48 from $46 at Barclays
10/16/20 Morgan Stanley
Comcast price target raised to $57 from $49 at Morgan Stanley
T AT&T
$26.80 /

-0.09 (-0.33%)

10/19/20 Wolfe Research
AT&T initiated with a Peer Perform at Wolfe Research
10/14/20 Jefferies
Apple price target raised to $140 from $135 at Jefferies
10/05/20
Fly Intel: Top five analyst downgrades
10/05/20 KeyBanc
AT&T downgraded to Underweight from Sector Weight at KeyBanc
T AT&T
$26.80 /

-0.09 (-0.33%)

NFLX Netflix
$526.10 /

-4.56 (-0.86%)

DIS Disney
$125.06 /

+0.8 (+0.64%)

CMCSA Comcast
$44.30 /

-0.01 (-0.02%)

T AT&T
$26.80 /

-0.09 (-0.33%)

NFLX Netflix
$526.10 /

-4.56 (-0.86%)

DIS Disney
$125.06 /

+0.8 (+0.64%)

T AT&T
$26.80 /

-0.09 (-0.33%)

NFLX Netflix
$526.10 /

-4.56 (-0.86%)

DIS Disney
$125.06 /

+0.8 (+0.64%)

CMCSA Comcast
$44.30 /

-0.01 (-0.02%)

T AT&T
$26.80 /

-0.09 (-0.33%)

NFLX Netflix
$526.10 /

-4.56 (-0.86%)

DIS Disney
$125.06 /

+0.8 (+0.64%)

CMCSA Comcast
$44.30 /

-0.01 (-0.02%)

On The Fly
Fly Intel: What to watch in Netflix earnings report » 13:29
10/20/20
10/20
13:29
10/20/20
13:29
NFLX

Netflix

$529.87 /

-0.79 (-0.15%)

, DIS

Disney

$125.02 /

+0.76 (+0.61%)

, AAPL

Apple

$118.60 /

+2.595 (+2.24%)

, AMZN

Amazon.com

$3,243.99 /

+34.08 (+1.06%)

, T

AT&T

$26.94 /

+0.05 (+0.19%)

, CMCSA

Comcast

$44.51 /

+0.2 (+0.45%)

Netflix (NFLX) is…

ShowHide Related Items >><<
T AT&T
$26.94 /

+0.05 (+0.19%)

NFLX Netflix
$529.87 /

-0.79 (-0.15%)

DIS Disney
$125.02 /

+0.76 (+0.61%)

CMCSA Comcast
$44.51 /

+0.2 (+0.45%)

AMZN Amazon.com
$3,243.99 /

+34.08 (+1.06%)

AAPL Apple
$118.60 /

+2.595 (+2.24%)

NFLX Netflix
$529.87 /

-0.79 (-0.15%)

10/21/20 JPMorgan
Netflix weakness on earnings a buying opportunity, says JPMorgan
10/21/20 KeyBanc
KeyBanc sees Netflix stock weakness as 'an overreaction'
10/21/20 Wells Fargo
Netflix price target raised to $510 from $470 at Wells Fargo
10/21/20 Canaccord
Netflix profits outperformed while subscriber growth slowed, says Canaccord
DIS Disney
$125.02 /

+0.76 (+0.61%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
AAPL Apple
$118.60 /

+2.595 (+2.24%)

10/20/20 Credit Suisse
New iPhone tracking similar to 11 cycle out of the gate, says Credit Suisse
10/15/20 BofA
Sonos upgraded to Buy at BofA after 'overdone' reaction to Apple news
10/14/20 Stifel
Stifel remains bullish on MKS, highlights exposure to flexible PCB market
10/14/20 KeyBanc
Apple iPhone launch positive for Broadcom, Qualcomm, says KeyBanc
AMZN Amazon.com
$3,243.99 /

+34.08 (+1.06%)

10/20/20 Citi
Citi likes Amazon head of Q3 results despite Prime Day language
10/19/20 Piper Sandler
Amazon Prime Day sales up 49% year-over-year, says Piper Sandler
10/16/20 Citi
Citi questions if Amazon's Prime Day may disappoint compared to last year
10/15/20 Truist
Truist says indications show Amazon Prime Day again a 'record sales period'
T AT&T
$26.94 /

+0.05 (+0.19%)

10/19/20 Wolfe Research
AT&T initiated with a Peer Perform at Wolfe Research
10/14/20 Jefferies
Apple price target raised to $140 from $135 at Jefferies
10/05/20
Fly Intel: Top five analyst downgrades
10/05/20 KeyBanc
AT&T downgraded to Underweight from Sector Weight at KeyBanc
CMCSA Comcast
$44.51 /

+0.2 (+0.45%)

10/20/20 Morgan Stanley
Charter price target raised to $750 from $700 at Morgan Stanley
10/16/20 Citi
Comcast price target raised to $52 from $49 at Citi
10/16/20 Barclays
Comcast price target raised to $48 from $46 at Barclays
10/16/20 Morgan Stanley
Comcast price target raised to $57 from $49 at Morgan Stanley
T AT&T
$26.94 /

+0.05 (+0.19%)

NFLX Netflix
$529.87 /

-0.79 (-0.15%)

DIS Disney
$125.02 /

+0.76 (+0.61%)

CMCSA Comcast
$44.51 /

+0.2 (+0.45%)

AMZN Amazon.com
$3,243.99 /

+34.08 (+1.06%)

AAPL Apple
$118.60 /

+2.595 (+2.24%)

T AT&T
$26.94 /

+0.05 (+0.19%)

NFLX Netflix
$529.87 /

-0.79 (-0.15%)

DIS Disney
$125.02 /

+0.76 (+0.61%)

AMZN Amazon.com
$3,243.99 /

+34.08 (+1.06%)

AAPL Apple
$118.60 /

+2.595 (+2.24%)

T AT&T
$26.94 /

+0.05 (+0.19%)

NFLX Netflix
$529.87 /

-0.79 (-0.15%)

DIS Disney
$125.02 /

+0.76 (+0.61%)

CMCSA Comcast
$44.51 /

+0.2 (+0.45%)

AMZN Amazon.com
$3,243.99 /

+34.08 (+1.06%)

AAPL Apple
$118.60 /

+2.595 (+2.24%)

T AT&T
$26.94 /

+0.05 (+0.19%)

NFLX Netflix
$529.87 /

-0.79 (-0.15%)

DIS Disney
$125.02 /

+0.76 (+0.61%)

CMCSA Comcast
$44.51 /

+0.2 (+0.45%)

AMZN Amazon.com
$3,243.99 /

+34.08 (+1.06%)

AAPL Apple
$118.60 /

+2.595 (+2.24%)

AAPL Apple
$118.60 /

+2.595 (+2.24%)

Conference/Events
Jefferies healthcare analysts to hold analyst/industry conference call » 09:44
10/20/20
10/20
09:44
10/20/20
09:44
AMGN

Amgen

$230.88 /

+0.03 (+0.01%)

, REGN

Regeneron

$583.98 /

+0.63 (+0.11%)

, AZN

AstraZeneca

$52.44 /

+ (+0.00%)

, SNY

Sanofi

$50.17 /

+ (+0.00%)

, GSK

GlaxoSmithKline

$36.18 /

+ (+0.00%)

Healthcare Analysts…

Healthcare Analysts Welford & Yee, along with an expert, discuss new treatments for asthma on an Analyst/Industry conference call to be held on October 20 at 10 am

ShowHide Related Items >><<
SNY Sanofi
$50.17 /

+ (+0.00%)

REGN Regeneron
$583.98 /

+0.63 (+0.11%)

GSK GlaxoSmithKline
$36.18 /

+ (+0.00%)

AZN AstraZeneca
$52.44 /

+ (+0.00%)

AMGN Amgen
$230.88 /

+0.03 (+0.01%)

AMGN Amgen
$230.88 /

+0.03 (+0.01%)

10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Truist
Amgen downgraded to Hold from Buy at Truist
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
REGN Regeneron
$583.98 /

+0.63 (+0.11%)

10/08/20 Benchmark
Regeneron antibody data 'more convincing' than Eli Lilly's, says Benchmark
10/07/20 Canaccord
Eli Lilly data further validates COVID antibody therapy, says Canaccord
10/05/20 Cantor Fitzgerald
Regeneron upgraded to Overweight from Neutral at Cantor Fitzgerald
10/05/20 Cantor Fitzgerald
Regeneron upgraded to Overweight from Neutral at Cantor Fitzgerald
AZN AstraZeneca
$52.44 /

+ (+0.00%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
SNY Sanofi
$50.17 /

+ (+0.00%)

10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
GSK GlaxoSmithKline
$36.18 /

+ (+0.00%)

10/15/20 SVB Leerink
SVB Leerink sees possible opportunity for Amarin to 'salvage Vascepa' in U.S.
10/12/20 UBS
GlaxoSmithKline price target lowered to 1,730 GBp from 1,800 GBp at UBS
10/09/20 Morgan Stanley
GlaxoSmithKline price target lowered to 1,695 GBp from 1,700 GBp at Morgan Stanley
10/08/20 JPMorgan
JPMorgan backs Neutral on GSK ahead of Q3 results
SNY Sanofi
$50.17 /

+ (+0.00%)

REGN Regeneron
$583.98 /

+0.63 (+0.11%)

GSK GlaxoSmithKline
$36.18 /

+ (+0.00%)

AZN AstraZeneca
$52.44 /

+ (+0.00%)

AMGN Amgen
$230.88 /

+0.03 (+0.01%)

  • 27
    May
SNY Sanofi
$50.17 /

+ (+0.00%)

REGN Regeneron
$583.98 /

+0.63 (+0.11%)

GSK GlaxoSmithKline
$36.18 /

+ (+0.00%)

AZN AstraZeneca
$52.44 /

+ (+0.00%)

AMGN Amgen
$230.88 /

+0.03 (+0.01%)

SNY Sanofi
$50.17 /

+ (+0.00%)

REGN Regeneron
$583.98 /

+0.63 (+0.11%)

GSK GlaxoSmithKline
$36.18 /

+ (+0.00%)

AZN AstraZeneca
$52.44 /

+ (+0.00%)

AMGN Amgen
$230.88 /

+0.03 (+0.01%)

SNY Sanofi
$50.17 /

+ (+0.00%)

REGN Regeneron
$583.98 /

+0.63 (+0.11%)

GSK GlaxoSmithKline
$36.18 /

+ (+0.00%)

AZN AstraZeneca
$52.44 /

+ (+0.00%)

AMGN Amgen
$230.88 /

+0.03 (+0.01%)

Hot Stocks
Cardiff Oncology reports new data from Phase 2 trial of onvansertib » 08:32
10/20/20
10/20
08:32
10/20/20
08:32
CRDF

Cardiff Oncology

$13.53 /

-1.37 (-9.19%)

Cardiff Oncology…

Cardiff Oncology announced that new data and analyses related to its ongoing Phase 2 trial of onvansertib in metastatic castration-resistant prostate cancer, or mCRPC, patients were featured in an electronic poster at the 27th Annual Prostate Cancer Foundation, or PCF, Scientific Retreat. The poster includes efficacy data demonstrating success in achieving the primary endpoint of disease control in patients showing initial resistance to Zytiga safety across three different dose and dosing schedules, as well as the potential clinical benefit for patients with the basal molecular tumor subtype. Cardiff Oncology is a clinical-stage biotechnology company and our mission is to develop new treatment options for cancer patients in indications with the greatest medical need.

ShowHide Related Items >><<
CRDF Cardiff Oncology
$13.53 /

-1.37 (-9.19%)

CRDF Cardiff Oncology
$13.53 /

-1.37 (-9.19%)

10/08/20
Fly Intel: Top five analyst initiations
10/08/20 Piper Sandler
Cardiff Oncology initiated with an Overweight at Piper Sandler
09/18/20 Maxim
Cardiff Oncology price target raised to $14 from $6 at Maxim
  • 30
    Sep
CRDF Cardiff Oncology
$13.53 /

-1.37 (-9.19%)

CRDF Cardiff Oncology
$13.53 /

-1.37 (-9.19%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.